Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05028153 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Azithromycin Treatment of Hospitalized Children With Asthmatic Symptoms

Study acronym: COPSACazt
StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date: Nov 13, 2025 to Nov 13, 2026v6
  2. Re-verified, no change to tracked fieldsv5
  3. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    v4
  4. Primary completion date: Oct 1, 2024 to Nov 13, 2025v3 Show 4 more changesShow less
    • Start date: Oct 1, 2022 to Nov 14, 2022
    • Enrollment target: 250 to 320
    • Study completion date: Oct 1, 2031 to Nov 13, 2032
    • Secondary endpoints: details revised at 8 of 12 entries
  5. Start date: Oct 1, 2021 to Oct 1, 2022v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this double-blind, randomized, controlled clinical trial is to investigate the effect of a three-day azithromycin treatment versus placebo treatment in children aged 1-5 years who are hospitalized due to asthma-like symptoms.
Trial Details
NCT Number NCT05028153
Lead Sponsor Copenhagen Studies on Asthma in Childhood
Conditions
(from sponsor)		 Childhood Asthma With Acute Exacerbation
Related terms Asthma, Infections, Respiratory Sounds
Enrollment 320 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov